I agree, I think managements decision to focus heavily on the FMCG's sector is starting to pay off right in front of our eyes. If they decided to put all the eggs into the pharmaceutical division basket i'm sure this company would not be looking so flash given the lead times for FMCG products are significantly shorterand not to mention bearing much more costs for testing/development.
We have signed off on two new licensing agreements with one more to come now i'm not sure if some on here are not aware of what licensing agreements are but in layman's tongue it's: "We are now ready to launch and distribute the products, unless the world burns down commercialisation is essentially guaranteed" (licensing with magnetic wand proceeded launch 5months prior). So i see managements hard work beginning to pay off albeit at snails pace. P&G would not continue with these licensing agreements if our technology wasn't as described on the packaging.
I'm more than happy with our current position, the SP doesn't reflect the progress but it will catch up in due time. Happy days.
OBJ Price at posting:
6.9¢ Sentiment: Hold Disclosure: Held
(20min delay)